Vijay Kumar Bhardwaj

According to our database, Vijay Kumar Bhardwaj authored at least 6 papers between 2020 and 2022.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2022

Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations.

Rahul Singh, Vijay Kumar Bhardwaj, Pralay Das, Dhananjay Bhattacherjee, Grigory V. Zyryanov, Rituraj Purohit

Comput. Biol. Medicine, 2022

2021

Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors.

Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Dinesh Kumar, Rituraj Purohit

Comput. Biol. Medicine, 2021

Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An <i>in-silico</i> approach.

Rahul Singh, Vijay Kumar Bhardwaj, Rituraj Purohit

Comput. Biol. Medicine, 2021

A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2.

Rahul Singh, Vijay Kumar Bhardwaj, Pralay Das, Rituraj Purohit

Comput. Biol. Medicine, 2021

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs.

Vijay Kumar Bhardwaj, Rahul Singh, Pralay Das, Rituraj Purohit

Comput. Biol. Medicine, 2021

2020

Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase.

Vijay Kumar Bhardwaj, Rahul Singh, Jatin Sharma, Pralay Das, Rituraj Purohit

Comput. Methods Programs Biomed., 2020